BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析

【英語タイトル】BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(SWOT20MY1336)・商品コード:SWOT20MY1336
・発行会社(調査会社):GlobalData
・発行日:2020年4月
・ページ数:53
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

BioDelivery Sciences International Inc (BDSI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company that develops and commercializes products in the areas of addiction medicine and pain management. The company’s marketed products include fentanyl buccal soluble solution for breakthrough cancer pain; buprenorphine/naloxone buccal film for opioid dependence; and buprenorphine buccal film for chronic pain. Its pipeline encompasses indications targeted at the treatment of chronic pain and opioid dependence. BDSI employs its proprietary BioErodible MucoAdhesive (BEMA) technology which comprises small, bioerodible polymer film used to facilitate rapid delivery a drug across the mucous membranes for time sensitive conditions. BDSI is headquartered in Raleigh, North Carolina, the US.

BioDelivery Sciences International Inc Key Recent Developments

Mar 12,2020: BioDelivery Sciences reports strong fourth quarter and full-year 2019 results
Mar 09,2020: BioDelivery Sciences appoints Jeffrey A. Bailey to its Board of Directors
Jan 29,2020: BioDelivery Sciences International, Inc. Expected to Post FY2019 Earnings of $0.08 Per Share …
Jan 13,2020: BDSI expects fourth quarter and 2019 total net sales at the high end of guidance
Jan 06,2020: BioDelivery Sciences appoints Kevin Ostrander as Senior Vice President of Business Development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
BioDelivery Sciences International Inc – Key Facts
BioDelivery Sciences International Inc – Key Employees
BioDelivery Sciences International Inc – Key Employee Biographies
BioDelivery Sciences International Inc – Major Products and Services
BioDelivery Sciences International Inc – History
BioDelivery Sciences International Inc – Company Statement
BioDelivery Sciences International Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioDelivery Sciences International Inc – Business Description
Business Segment: Contract Revenue
Overview
Performance
Business Segment: Product Royalty Revenue
Overview
Performance
Business Segment: Product Sales
Overview
Performance
Business Segment: Research and Development Reimbursements
Performance
BioDelivery Sciences International Inc – Corporate Strategy
BioDelivery Sciences International Inc – SWOT Analysis
SWOT Analysis – Overview
BioDelivery Sciences International Inc – Strengths
BioDelivery Sciences International Inc – Weaknesses
BioDelivery Sciences International Inc – Opportunities
BioDelivery Sciences International Inc – Threats
BioDelivery Sciences International Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
BioDelivery Sciences International Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 12, 2020: BioDelivery Sciences reports strong fourth quarter and full-year 2019 results
Mar 09, 2020: BioDelivery Sciences appoints Jeffrey A. Bailey to its Board of Directors
Jan 13, 2020: BDSI expects fourth quarter and 2019 total net sales at the high end of guidance
Jan 06, 2020: BioDelivery Sciences appoints Kevin Ostrander as Senior Vice President of Business Development
Nov 25, 2019: BioDelivery Sciences appoints Dr. Vanila Singh, former Chief Medical Officer of Health and Human Services, to its Board of Directors
Nov 12, 2019: BioDelivery Sciences reports strong third quarter results, raises full year 2019 and provides 2020 net sales expectations
Aug 08, 2019: BioDelivery Sciences reports strong second quarter 2019 results and raises net sales expectations
May 28, 2019: BioDelivery Sciences strengthens financial position with debt refinancing
May 06, 2019: BioDelivery Sciences reports strong first quarter 2019 results and raises BELBUCA full-year expectations
Mar 14, 2019: BioDelivery Sciences reports strong 2018 results and 2019 expectations
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
BioDelivery Sciences International Inc, Key Facts
BioDelivery Sciences International Inc, Key Employees
BioDelivery Sciences International Inc, Key Employee Biographies
BioDelivery Sciences International Inc, Major Products and Services
BioDelivery Sciences International Inc, History
BioDelivery Sciences International Inc, Subsidiaries
BioDelivery Sciences International Inc, Key Competitors
BioDelivery Sciences International Inc, Ratios based on current share price
BioDelivery Sciences International Inc, Annual Ratios
BioDelivery Sciences International Inc, Annual Ratios (Cont...1)
BioDelivery Sciences International Inc, Interim Ratios
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
BioDelivery Sciences International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
BioDelivery Sciences International Inc, Performance Chart (2015 - 2019)
BioDelivery Sciences International Inc, Ratio Charts
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★調査レポート[BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析] (コード:SWOT20MY1336)販売に関する免責事項を必ずご確認ください。
★調査レポート[BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆